IP Library Granted Patent US 9,676,698
Granted Patent B2
US 9,676,698 · App. 15/178,112 · Granted Jun 13, 2017

Method of producing ingenol-3-angelate

Inventors: Thomas Hogberg (Akarp, SE); Gunnar Grue-Sorensen (Roskilde, DK); Xifu Liang (Glostrup, DK); Anne Marie Horneman (Humlebaek, DK); Anders Klarskov Petersen (Naerum, DK)
Assignee: LEO Laboratories Limited
C07C67/08C07C49/753C07C59/90C07C67/14C07C67/297C07D317/70C07D319/08C07D493/08C07F7/184C07F7/1856C07C2103/86C07C2103/98Y02P20/55
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,676,698
App. No.
15/178,112
Granted
Jun 13, 2017
Kind
B2
Abstract

The present invention relates to methods of producing ingenol-3-angelate (I) from ingenol (II). Furthermore, the invention relates to intermediates useful for the synthesis of ingenol-3-angelate (I) from ingenol (II) and to methods of producing said intermediates.

Claims (36)

1. A method of producing a product comprising ingenol-3-angelate (I),

comprising the steps of:

esterifying ingenol protected with a dihydroxyl protecting group at the 5 and 20 positions, with angelic acid or a derivative thereof selected from the group consisting of angelic acid, methyl angelate, vinyl angelate, angeloyl chloride, angelic anhydride, angeloyl 2,4,6-trichlorobenzoyl anhydride, [(Z)-2-methylbut-2-enoyl]2,4,6-trichlorobenzoate, and angeloyl 4-nitrobenzoyl anhydride in the presence of a base to produce 5, 20 hydroxyl-protected ingenol-3-angelate (VI), wherein D represents a dihydroxyl protecting group; and

removing the dihydroxyl protecting group at the 5 and 20 positions to produce the product comprising ingenol-3-angelate (I).

2. The method of claim 1 , wherein the base is selected from the group consisting of a disilazide salt and a carbonate salt.

3. The method of claim 2 , wherein the base is selected from the group consisting of lithium hexamethyldisilazide, sodium hexamethyldisilazide, potassium hexamethyldisilazide, and cesium carbonate.

4. The method of claim 2 , wherein the base is a disilazide salt.

5. The method of claim 4 , wherein the disilazide salt is lithium hexamethyldisilazide, sodium hexamethyldisilazide, or potassium hexamethyldisilazide.

6. The method of claim 1 , wherein the dihydroxyl protecting group is selected from the group consisting of ketals and acetals.

7. The method of claim 1 , wherein the 5, 20-protected ingenol is ingenol-5, 20-acetonide (Compound 1):

8. A method of producing a product comprising ingenol-3-angelate (I),

comprising the steps of:

converting angelic acid to angelic anhydride;

esterifying ingenol protected with a dihydroxyl protecting group at the 5 and 20 positions, with angelic anhydride in the presence of a base to produce 5, 20 hydroxyl-protected ingenol-3-angelate (VI), wherein D represents a dihydroxyl protecting group; and

removing the dihydroxyl protecting group at the 5 and 20 positions to produce the product comprising ingenol-3-angelate (I).

9. The method of claim 8 , wherein the converting step comprises mixing angelic acid with a coupling reagent.

10. The method of claim 9 , wherein the coupling reagent is N,N′-dicyclohexylcarbodiimide (DCC), 1-methyl-2-chloro-pyridinium iodide, O-(benzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate (HBTU), 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride (DMTMM), N,N,N′,N′-tetramethyl-O-(7-azabenzotriazol-1-yl)uronium hexafluorophosphate (HATU), or N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDCI).

11. The method of claim 9 , wherein the coupling reagent is N,N′-dicyclohexylcarbodiimide (DCC).

12. The method of claim 8 , wherein the angelic anhydride is purified by chromatography.

13. The method of claim 8 , wherein the base is a non-nucleophilic base.

14. The method of claim 8 , wherein the base is selected from the group consisting of lithium hexamethyldisilazide, sodium hexamethyldisilazide, potassium hexamethyldisilazide, and cesium carbonate.

15. The method of claim 8 , wherein the dihydroxyl protecting group is selected from the group consisting of ketals and acetals.

16. The method of claim 8 , wherein the 5, 20-protected ingenol is ingenol-5, 20-acetonide (Compound 1):

17. The method of claim 8 , wherein the esterifying step has a yield of at least 90%.

18. The method of claim 17 , wherein the product comprises ingenol-3-tiglate and ingenol-3-angelate (I) at a molar ratio of at most 5:95.

19. A method of producing a product comprising ingenol-3-angelate (I),

comprising the steps of:

esterifying ingenol protected with a dihydroxyl protecting group at the 5 and 20 positions, with angelic anhydride or angelic chloride in the presence of a base to produce 5, 20 hydroxyl-protected ingenol-3-angelate (VI), wherein D represents a dihydroxyl protecting group; and

removing the dihydroxyl protecting group at the 5 and 20 positions to produce the product comprising ingenol-3-angelate (I);

wherein the product comprises ingenol-3-tiglate and the ingenol-3-angelate (I) at a molar ratio of at most 5:95.

20. The method of claim 19 , wherein the product comprises ingenol-3-tiglate and the ingenol-3-angelate (I) at a molar ratio of at most 3:97.

21. The method of claim 19 , wherein the product comprises ingenol-3-tiglate and the ingenol-3-angelate (I) at a molar ratio of at most 2:98.

22. The method of claim 19 , wherein the base is non-nucleophilic.

23. The method of claim 19 , wherein the dihydroxyl protecting group is selected from the group consisting of ketals and acetals.

24. The method of claim 22 , wherein the base is selected from the group consisting of a disilazide salt and a carbonate salt.

25. The method of claim 24 , wherein the dihydroxyl protecting group is selected from the group consisting of ketals and acetals.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 9, 2016
From: HOGBERG, THOMAS; GRUE-SORENSEN, GUNNAR; LIANG, XIFU; HORNEMAN, ANNE MARIE; PETERSEN, ANDERS KLARSKOV
To: LEO LABORATORIES LIMITED
Reel/Frame 038863/0979 →
Continuity (4)
Continuation 14557302 · Dec 1, 2014
Continuation 13811207
Provisional Application 61366018 · Jul 20, 2010
Related Publication 20160280627A1 · Sep 29, 2016